PSN at 55: The distance between what we can do and what we can deliver
Fifty-five years in, we are still trying to reconcile what modern Medicine allows with what our patients can sustain.

For 55 years, the Philippine Society of Nephrology (PSN) has quietly expanded what we can do — training doctors, building dialysis units, performing transplants, writing guidelines, holding conferences. Work that rarely trends, rarely goes viral, rarely makes headlines, but keeps people alive.
Because in Nephrology, survival is not dramatic. It is repetitive. Measured in sessions, counted in laboratory values, sustained in routines most people never see — three times a week, four hours at a time, for years. That is the system we built. That is our capability. And for a long time, we called that progress.
And it was.
We now have transplant programs that can stand beside those in more developed countries, access to modern immunosuppressive therapies, advanced diagnostics and dialysis machines that do exactly what they are meant to do — reliably, quietly, every single day.
On paper, it reads like a success story. But anniversaries are not just for looking back. They are for asking harder questions. Because if we are honest, the real story of Nephrology in the Philippines is not just about what we can do. It is about the distance between what we can do — and what we can consistently deliver.

Dr. Brian Michael I. Cabral presents the latest KDIGO 2026 updates on the evaluation and management of renal anemia, highlighting evidence-based strategies to optimize hemoglobin targets and iron utilization during the 55th anniversary celebration of Philippine Society of Nephrology and 46th PSN Annual Convention at the EDSA Shangri-La Manila. Dr. Cabral discusses key recommendations and emerging therapies that aim to improve patient outcomes while minimizing treatment-related risks.
Photograph courtesy of Philippine Society of Nephrology
That distance is where our patients live.
We have built a system capable of delivering world-class care — and yet access remains uneven, unpredictable, and at times, out of reach. We discuss antibody-mediated rejection in conference rooms while patients quietly calculate whether they can afford their next dialysis session. We refine transplant protocols to the smallest detail while others miss treatments for reasons that have nothing to do with medicine. We speak the language of precision, but we practice in a reality shaped by limitation.
During the Covid years, that contrast became impossible to ignore. Dialysis units did not shut down; kidney failure does not wait for pandemics to pass. While much of the world slowed, Nephrology did not. Patients still needed to be dialyzed, lines still had to be inserted, complications still had to be managed. There were no work-from-home options for kidney failure — no delays, no pauses. We showed up, day after day, in full protective gear, in units never designed for outbreaks, in systems stretched beyond what anyone thought possible. Not because it was heroic, but because there was no alternative. Patients either received dialysis, or they did not. And if they did not, the outcome was never in doubt.


